Skip to main content
. 2012 Aug;56(8):4103–4111. doi: 10.1128/AAC.00360-12

Table 3.

Composite survival data

Compound % survival (no. surviving/total no.)
Day 5 Day 12
Uninfected control 81 (18/22) 45 (10/22)
Infected control 14 (6/42) 12 (5/42)
Vancomycin 94 (32/34) 15 (5/34)
Amixicile 56 (23/42) 56 (23/42)
Nitazoxanide 22 (7/32) 22 (7/32)
Fidaxomicin 80 (8/10) 20 (2/10)